Neuro-Sys

Executive Summary

Neuro-Sys is a Paris-based contract research organization (CRO) specializing in advanced in vitro and in vivo models for neurodegenerative disease drug discovery. Founded in 2016, the company supports clients in the CNS and PNS fields, offering expertise in mode of action research and drug development. With a team of 11-50 employees and a globally recognized reputation, Neuro-Sys addresses the critical need for reliable preclinical models in neuroscience, a therapeutic area with high unmet medical need and significant R&D spending from large pharma and biotech firms. The company's position as a specialized CRO in a niche but growing market provides a strong foundation for growth. As neurodegenerative disease pipelines expand, demand for high-quality preclinical services is expected to rise. While Neuro-Sys is private and pre-clinical (as a service provider), it may be an attractive acquisition target for larger CROs seeking to augment their neuroscience capabilities. Key risks include competition from established CROs and dependency on client spending. Overall, Neuro-Sys presents a compelling opportunity in the neuroscience CRO space, with potential for steady revenue growth and strategic partnerships.

Upcoming Catalysts (preview)

• Q3 2026Launch of Novel 3D Neurosphere Model Platform75% success
• Q2 2026Strategic Partnership with Top-20 Pharma for Alzheimer's Program60% success
• Q4 2026Publication of Validation Data for Parkinson's Disease Model85% success